Dynamics of Nitroglycerin-induced Exhaled Nitric Oxide After Lung Transplantation: Evidence of Pulmonary Microvascular Injury?

Journal of Heart and Lung Transplantation

Volumn 26, Issue 12, 2007, Pages 1300-1305

  Gal, Janos ^a,b   Kovesi, Tamas ^b   Royston, David ^b   Marczin, Nándor ^a,b  

^a Faculty of Medicine   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE; NITRIC OXIDE;

ADULT; ARTICLE; BREATH ANALYSIS; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EXPIRED AIR; FEMALE; HEART SURGERY; HUMAN; ISCHEMIA; LUNG BLOOD FLOW; LUNG INJURY; LUNG TRANSPLANTATION; MALE; MICROANGIOPATHY; NON INVASIVE MEASUREMENT; ORGAN DONOR; POINT OF CARE TESTING; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; RECIPIENT; REPERFUSION INJURY;

ADULT; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; EXHALATION; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG; LUNG TRANSPLANTATION; MALE; MICROCIRCULATION; NITRIC OXIDE; NITROGLYCERIN; REPERFUSION INJURY; TIME FACTORS;

EID: 37149039271     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.09.033     Document Type: Article

References (44)

1. Christie J.D., Bavaria J.E., Palevsky H.I., et al. Primary graft failure following lung transplantation. Chest 114 (1998) 51-60
2. Gammie J.S., Cheul L.J., Pham S.M., et al. Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg 115 (1998) 990-997
3. Khan S.U., Salloum J., O'Donovan P.B., et al. Acute pulmonary edema after lung transplantation: the pulmonary reimplantation response. Chest 116 (1999) 187-194
4. Pinsky D.J. The vascular biology of heart and lung preservation for transplantation. Thromb Haemost 74 (1995) 58-65
5. Naka Y., Toda K., Kayano K., et al. Failure to express the P-selectin gene or P-selectin blockade confers early pulmonary protection after lung ischemia or transplantation. Proc Natl Acad Sci USA 94 (1997) 757-761
6. Barnes P.J., and Belvisi M.G. Nitric oxide and lung disease. Thorax 48 (1993) 1034-1043
7. Marczin N., and Royston D. Nitric oxide as mediator, marker and modulator of microvascular damage in ARDS. Br J Anaesth 87 (2001) 179-183
8. Pinsky D.J., Naka Y., Chowdhury N.C., et al. The nitric oxide/cyclic GMP pathway in organ transplantation: critical role in successful lung preservation. Proc Natl Acad Sci USA 91 (1994) 12086-12090
9. Naka Y., Chowdhury N.C., Liao H., et al. Enhanced preservation of orthotopically transplanted rat lungs by nitroglycerin but not hydralazine. Requirement for graft vascular homeostasis beyond harvest vasodilation. Circ Res 76 (1995) 900-906
10. Naka Y., Chowdhury N.C., Oz M.C., et al. Nitroglycerin maintains graft vascular homeostasis and enhances preservation in an orthotopic rat lung transplant model. J Thorac Cardiovasc Surg 109 (1995) 206-210
11. Egan T.M., Hoffmann S.C., Sevala M., Sadoff J.D., and Schlidt S.A. Nitroglycerin reperfusion reduces ischemia-reperfusion injury in non-heart-beating donor lungs. J Heart Lung Transplant 25 (2006) 110-119
12. Gomez C.B., del Valle H.F., Bertolotti B., et al. Effects of short-term inhaled nitric oxide on interleukin-8 release after single-lung transplantation in pigs. J Heart Lung Transplant 24 (2005) 714-722
13. Lepore J.J., Dec G.W., Zapol M.W., Bloch K.D., and Semigran M.J. Combined administration of intravenous dipyridamole and inhaled nitric oxide to assess reversibility of pulmonary arterial hypertension in potential cardiac transplant recipients. J Heart Lung Transplant 24 (2005) 1950-1956
14. Naka Y., Roy D.K., Smerling A.J., et al. Inhaled nitric oxide fails to confer the pulmonary protection provided by distal stimulation of the nitric oxide pathway at the level of cyclic guanosine monophosphate. J Thorac Cardiovasc Surg 110 (1995) 1434-1440
15. Meade M., Granton J.T., Matte-Martyn A., et al. A randomized trial of inhaled nitric oxide to prevent reperfusion injury following lung transplantation. J Heart Lung Transplant 20 (2001) 254-255
16. Kharitonov S., Alving K., and Barnes P.J. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J 10 (1997) 1683-1693
17. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171 (2005) 912-930
18. Marczin N., Riedel B., Gal J., Polak J., and Yacoub M. Exhaled nitric oxide during lung transplantation. Lancet 350 (1997) 1681-1682
19. Brett S.J., and Evans T.W. Measurement of endogenous nitric oxide in the lungs of patients with the acute respiratory distress syndrome. Am J Respir Crit Care Med 157 (1998) 993-997
20. Carlin R.E., Ferrario L., Boyd J.T., et al. Determinants of nitric oxide in exhaled gas in the isolated rabbit lung. Am J Respir Crit Care Med 155 (1997) 922-927
21. Silkoff P.E., Erzurum S.C., Lundberg J.O., et al. ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc 3 (2006) 131-145
22. Dweik R.A., Laskowski D., Abu-Soud H.M., et al. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 101 (1998) 660-666
23. Marczin N., Riedel B., Royston D., and Yacoub M. Intravenous nitrate vasodilators and exhaled nitric oxide. Lancet 349 (1997) 1742
24. Kovesi T., Royston D., Yacoub M., and Marczin N. Basal and nitroglycerin-induced exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass. Br J Anaesth 90 (2003) 608-616
25. Marczin N., Kovesi T., and Royston D. Exhaled nitric oxide as a marker of lung injury in coronary artery bypass surgery. Br J Anaesth 90 (2003) 101-104
26. Marczin N. The biology of exhaled nitric oxide (NO) in ischemia-reperfusion-induced lung injury: a tale of dynamism of NO production and consumption. Vasc Pharmacol 43 (2005) 415-424
27. Marczin N., Ryan U.S., and Catravas J.D. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. Circ Res 70 (1992) 326-340
28. Morita K., Ihnken K., Buckberg G.D., and Ignarro L.J. Oxidative insult associated with hyperoxic cardiopulmonary bypass in the infantile heart and lung. Jpn Circ J 60 (1996) 355-363
29. Beghetti M., Silkoff P.E., Caramori M., et al. Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury. Ann Thorac Surg 66 (1998) 532-534
30. Ishibe Y., Liu R., Hirosawa J., et al. Exhaled nitric oxide level decreases after cardiopulmonary bypass in adult patients. Crit Care Med 28 (2000) 3823-3827
31. Cuthbertson B.H., Stott S.A., and Webster N.R. Exhaled nitric oxide as a marker of lung injury in coronary artery bypass surgery. Br J Anaesth 89 (2002) 247-250
32. Tornberg D.C., Angdin M., Settergen G., et al. Exhaled nitric oxide before and after cardiac surgery with cardiopulmonary bypass-response to acetylcholine and nitroglycerin. Br J Anaesth 94 (2005) 174-180
33. Sartori C., Lepori M., Busch T., et al. Exhaled nitric oxide does not provide a marker of vascular endothelial function in healthy humans. Am J Respir Crit Care Med 160 (1999) 879-882
34. Marczin N. Exhaled nitric oxide and cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 126 (2003) 1673-1674
35. Persson M.G., Agvald P., and Gustafsson L.E. Detection of nitric oxide in exhaled air during administration of nitroglycerin in vivo. Br J Pharmacol 111 (1994) 825-828
36. Cederqvist B., Persson M.G., and Gustafsson L.E. Direct demonstration of NO formation in vivo from organic nitrites and nitrates, and correlation to effects on blood pressure and to in vitro effects. Biochem Pharmacol 47 (1994) 1047-1053
37. Husain M., Adrie C., Ichinose F., Kavosi M., and Zapol W.M. Exhaled nitric oxide as a marker for organic nitrate tolerance. Circulation 89 (1994) 2498-2502
38. Hansson G.K., Jornvall H., and Lindahl S.G. [The Nobel Prize 1998 in physiology or medicine. Nitrogen oxide as a signal molecule in the cardiovascular system. ] Ugeskr Laeger 160 (1998) 7571-7578
39. Fung H.L. Biochemical mechanism of nitroglycerin action and tolerance: is this old mystery solved?. Annu Rev Pharmacol Toxicol 44 (2004) 67-85
40. Kovesi T., Royston D., Yacoub M.Y., and Marczin N. Exhaled nitric oxide in human lung ischaemia-reperfusion. In: Marczin N., Kharitonov S.A., Yacoub M.H., and Barnes P.J. (Eds). Disease markers in exhaled breath. Lung biology in health and disease 170 (2003), Marcel Dekker, New York 259-279
41. Fung H.L., Chung S.J., Bauer J.A., Chong S., and Kowaluk E.A. Biochemical mechanism of organic nitrate action. Am J Cardiol 70 (1992) 4B-10B
42. Haddad I.Y., Pataki G., Hu P., Galliani C., Beckman J.S., and Matalon S. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J Clin Invest 94 (1994) 2407-2413
43. Munzel T., and Harrison D.G. Evidence for a role of oxygen-derived free radicals and protein kinase C in nitrate tolerance. J Mol Med 75 (1997) 891-900
44. Dikalov S., Fink B., Skatchkov M., Stalleicken D., and Bassenge E. Formation of reactive oxygen species by pentaerithrityltetranitrate and glyceryl trinitrate in vitro and development of nitrate tolerance. J Pharmacol Exp Ther 286 (1998) 938-944